X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Nature Reviews Clinical Oncology

期刊標題檢索 NAT REV CLIN ON 最新評論: Review speed: 3.0 | Submission acceptance rate: 5.0 Emphasized resea... (2022-04-14)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Nature Reviews Clinical Oncology]您好,您是該頁面的第 37466 位訪客。

期刊簡介
期刊名稱Nature Reviews Clinical Oncology Nature Reviews Clinical Oncology
LetPub Score
9.7
50 ratings
Rate

Reputation
10.0

Influence
9.4

Speed
9.7

期刊簡稱NAT REV CLIN ONCOL
ISSN1759-4774
E-ISSN1759-4782
h-index127
CiteScore
CiteScoreSJRSNIPCiteScore Rank
99.4021.04810.846
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q13 / 404

自引率 (2023-2024)0.60%自引率趨勢
掲載範囲
Nature Reviews' clinical content is written by internationally renowned clinical academics and researchers and targeted towards readers in the medical sciences, from postgraduate level upwards. While intended to be read by practicing doctors, researchers and academics within a specialty, we aim to make all our articles accessible to readers working in any medical discipline. In-depth Reviews present authoritative, up-to-date information on a topic, placing it in the context of a field's history and development. Topical discussion and opinions are proffered in Perspectives and News & Views articles, and in the Research Highlights section we filter primary research from a range of specialty and general medical journals.
官方網站https://www.nature.com/nrclinonc
在線稿件提交https://mts-nrclinonc.nature.com/
開放訪問No
出版商Springer Nature
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年2009
每年文章數51每年文章數趨勢
黃金OA百分比1.47%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ12/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1759-4774%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Very difficult
參考鏈接
相關期刊 【Nature Reviews Clinical Oncology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    CLINICAL CANCER RESEARCHH-index: 292

    CiteScore: 20.10
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS332380
    CANCER RESEARCH312319
    BMC CANCER246077
    Asian Pacific Journal of Cancer Prevention221125
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198028
    INTERNATIONAL JOURNAL OF CANCER192069
    CLINICAL CANCER RESEARCH181695
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY177505
    ONCOLOGY REPORTS175438
    CA-A CANCER JOURNAL FOR CLINICIANS163698
  •  

    Nature Reviews Clinical Oncology Nature Reviews Clinical Oncology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Nature Reviews Clinical Oncology] 的評論撰寫評論
作者: 法慧和同


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-14 18:16:41 評論於
Review speed: 3.0 | Submission acceptance rate: 5.0
Emphasized research areas: cancer; tumors; review
Experience sharing: This journal is highly prestigious!!
(0) 讚! | 法慧和同

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:23:52 評論於
Contrary to the introduction, the writing of the discussion section follows a reverse funnel structure that expands from small to large. Starting from the reasonableness of each research result, anomalies, and the underlying principles, a thorough analysis is slowly conducted. After laying the groundwork, the main conclusions of the paper can naturally be discussed, followed by a broader analysis highlighting the importance/relevance/applicability/value of the research
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:34:14 評論於
There are no fixed requirements for paragraphing in the discussion, so please write according to your own circumstances
(0) 讚! | 维尔娜菲茨杰拉德

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 22:55:27 評論於
How many paragraphs are there in a typical discussion?
(0) 讚! | 平原文波

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 16:40:49 評論於
What is the difference between an introduction and a discussion?
(0) 讚! | 八坂篷蔚

作者: 重阳文景


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-03-02 14:11:37 評論於
Why does nature have so many review journals under its umbrella?
(0) 讚! | 重阳文景

作者: 重阳文景


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-03-02 12:38:07 評論於
Is it necessary? Why does Nature's subsidiary have so many review journals?
(0) 讚! | 重阳文景

作者: 香风寻山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-05-20 22:28:48 評論於
The chain of transmission of human viruses causing cancer has been cured by traditional Chinese medicine since February 25, 2016
(0) 讚! | 香风寻山

作者: 是你的紫安呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-05-20 21:23:09 評論於
Human virus pathogenic transmission chain causes cancer, and traditional Chinese medicine cures it. First uploaded on February 25, 2016
(0) 讚! | 是你的紫安呀

作者: 江南福萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-05-20 17:24:23 評論於
The chain of transmission of human viruses causing cancer was cured by traditional Chinese medicine. First uploaded on 2016.02.25
(0) 讚! | 江南福萍

作者: 七濑东菊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-05-20 09:03:58 評論於
Review Speed: 1.0 Experience Sharing: Human Virus Pathogenic Transmission Chain Causes Cancer, Traditional Chinese Medicine Cures. First uploaded on 2016.02.25
(0) 讚! | 七濑东菊

作者: gfzywks@163.com


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2018-05-20 01:42:00 評論於
human virus pathogenic transmission chain carcinogenic Chinese medicine cure.Since 2016.02.25. first upload
(0) 讚! | gfzywks@163.com

作者: gfzywks@163.com


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2018-05-20 01:41:59 評論於
human virus pathogenic transmission chain carcinogenic Chinese medicine cure.Since 2016.02.25. first upload
(0) 讚! | gfzywks@163.com

作者: gfzywks@163.com


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2018-05-20 01:41:58 評論於
human virus pathogenic transmission chain carcinogenic Chinese medicine cure.Since 2016.02.25. first upload
(0) 讚! | gfzywks@163.com

作者: gfzywks@163.com


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2018-05-20 01:40:28 評論於
My article was on the human virus pathogenic transmission chain. I submitted it on 2016.02.25.

(0) 讚! | gfzywks@163.com

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 14:55:09 評論於
Who can predict how many points there will be next year?
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-07-03 10:04:12 評論於
Research focus: Tumors; Cancer
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 20:47:43 評論於
Focused research areas: Tumors; Cancer
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 13:09:28 評論於
Research Focus: Tumors; Cancer
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Nature Reviews Clinical Oncology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*